Kushenin combined with entecavir for chronic hepatitis B: A protocol for a systematic review and meta-analysis.

Author: JinYuxia, WangYunxia, XiaoXiao, ZhangJiayuan, ZhangQi

Overview

This study aims to evaluate the efficacy and safety of kushenin (KS) combined with entecavir (ETV) for chronic hepatitis B.

Paper Details　

Original Abstract of the Article :

A recent study has reported that there are >240 million patients infected with chronic hepatitis B (CHB) worldwide. Once patients with CHB start antiviral treatment, they need to take antiviral drugs for a long period, which may lead to a series of side effects, and the resistance to the antiviral d...See full text at original site

Dr.Camel's Paper Summary Blog

Kushenin Combined with Entecavir for Chronic Hepatitis B: A Protocol for a Systematic Review and Meta-Analysis

This study proposes a systematic review and meta-analysis to evaluate the efficacy and safety of combining kushenin, a traditional Chinese medicine, with entecavir, an antiviral medication, for treating chronic hepatitis B (CHB). The study aims to assess the combined effect of these two treatments on viral suppression, liver function, and overall health outcomes.

Exploring Traditional Medicine for Hepatitis B: A Camel's Perspective

Just as a camel utilizes natural resources in the desert for its survival, humans have long relied on traditional medicine for healing. This research explores the potential benefits of combining traditional Chinese medicine with modern antiviral therapies for treating chronic hepatitis B. It's like finding a hidden oasis of knowledge and wisdom in the vast desert of medicine.

Dr.Camel's Conclusion

This systematic review and meta-analysis aims to provide a comprehensive assessment of the efficacy and safety of combining kushenin with entecavir for treating CHB. This research offers a potential path to improving treatment options for patients with chronic hepatitis B, combining the wisdom of traditional medicine with the advancements of modern science.